BioNTech
Showing 1 - 25 of 197
COVID-19 Vaccines Using Information From California State
Not yet recruiting
- SARS-CoV-2
- +2 more
- Pfizer-BioNTech COVID-19 bivalent mRNA vaccine
- (no location specified)
May 23, 2023
COVID-19 Respiratory Infection Trial in Sulaymaniyah (Vitamin-D)
Completed
- COVID-19 Respiratory Infection
- Vitamin-D
-
Sulaymaniyah, IraqHawal Lateef Fateh
May 10, 2023
Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study -
Recruiting
- COVID-19
- Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine
-
Pasadena, CaliforniaKaiser Permanente Southern California
Sep 21, 2022
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023
COVID-19 Trial in Hong Kong (Intervention)
Recruiting
- COVID-19
- Intervention group
- Control group
-
Hong Kong, Hong KongCentre of Safe Medication Practice and Research
Nov 3, 2022
COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)
Active, not recruiting
- COVID-19
- Tozinameran - Standard dose
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital
Aug 24, 2022
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
COVID-19 Vaccines Trial in Paris (2nd booster with Comirnaty® (Pfizer-BioNTech), CoV2 preS dTM adjuvanted vaccine (B.1.351),
Active, not recruiting
- COVID-19 Vaccines
- 2nd booster with Comirnaty® (Pfizer-BioNTech)
- CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)
Not yet recruiting
- COVID-19
- Pfizer-BioNTech Standard dose
- +5 more
-
Bandung, West Java, Indonesia
- +2 more
Nov 30, 2022
COVID-19, Vaccine Reaction Trial in Paris (BNT162b2, CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK, CoV2 preS dTM
Active, not recruiting
- COVID-19
- Vaccine Reaction
- BNT162b2
- +2 more
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022
COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)
Not yet recruiting
- COVID-19
- Tozinameran
- +3 more
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022
COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)
Recruiting
- COVID-19
- Lymph node aspiration / Blood sampling
-
Paris, FranceGH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023
SARS CoV 2 Infection, COVID-19 Trial in Brownsville, Edinburg, Rio Grande City (Pfizer/BioNTech (BNT162b2), Moderna)
Recruiting
- SARS CoV 2 Infection
- COVID-19
- Pfizer/BioNTech (BNT162b2)
- Moderna
-
Brownsville, Texas
- +3 more
Mar 14, 2022
Advanced Endometrial Cancer Trial (Pembrolizumab, GEN1046)
Not yet recruiting
- Advanced Endometrial Cancer
- Pembrolizumab
- GEN1046
- (no location specified)
Sep 14, 2023
Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood
Not yet recruiting
- Fever After Vaccination
- +2 more
- Pfizer-BioNTech COVID-19 Vaccine
- Routine Childhood Vaccinations
-
Oakland, California
- +4 more
Sep 8, 2023
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Not yet recruiting
- Covid-19 Pandemics
- Tuberculosis
- Pfizer-BioNTech COVID-19 vaccine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
Covid19 Vaccine Trial in Canada, South Africa (PTX-COVID19-B, Pfizer-BioNTech COVID-19 vaccine, Placebo)
Active, not recruiting
- Covid19 Vaccine
- PTX-COVID19-B
- +2 more
-
Mississauga, Ontario, Canada
- +9 more
Apr 22, 2022
Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))
Active, not recruiting
- Kidney Transplant Recipients
- mRNA-1273 vaccine (Pfizer/BioNTech)
- mRNA-1273 vaccine (Moderna)
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 4, 2021
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Solid Tumor Trial in Tokyo (GEN1046)
Recruiting
- Solid Tumor
- GEN1046
-
Tokyo, Japan
- +1 more
Jan 13, 2023
Covid19 Trial in Antwerp (immunogenicity after first and second dose)
Enrolling by invitation
- Covid19
- immunogenicity after first and second dose
-
Antwerp, BelgiumMensura EDPB
Oct 18, 2021
Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)
Recruiting
- Adenocarcinoma, Pancreatic Ductal
- Autogene cevumeran
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 21, 2023
BNT162b2 mRNA Covid-19 Vaccine in Brazil
Recruiting
- Covid19
- Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
- +3 more
-
Toledo, Paraná, BrazilPronto Atendimento Municipal de Toledo
Dec 14, 2021
COVID-19 Infection, COVID-19 VACCINE Trial in Thailand (AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose, Pfizer/BioNTech
Completed
- COVID-19 Infection
- COVID-19 VACCINE
- AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose
- +3 more
-
Bangkok Noi, Bangkok, Thailand
- +6 more
Jul 3, 2022